Skip to main content
Smart Investors Daily
AK

NASDAQ · AKAN

Akanda Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

$3.86

Down-$0.04 (-1.03%)

Updated Aug 23, 2026, 9:46 AM

SID Score

3.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
151.47K
P/E ratio
-0.19
Dividend yield
0.00%
52-week range
$2.30 – $209.03
Volume
164.81K
Avg. volume
1.36M

Price performance

AKAN price history

1M range · 0 trading sessions · Daily adjusted prices

AKAN does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest AKAN news

The latest Smart Investors Daily articles mentioning AKAN.

AKAN research

Overview

Company profile and research snapshot.

Company profile

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Aug 17, 2026

Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings, Expion360, Skye Bioscience, Julong Holding, FIEE Inc, and Keel Infrastructure. Losers include Generation Income Properties, Barfresh Food Group, iTonic Holdings, Akanda Corp, and Reservoir Media.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.